COVID Meds Like Paxlovid Will No Longer Be a Freebie
Paxlovid and Other COVID Treatments to Come with Hefty Price Tags in the Near Future
Pricey COVID Meds like Paxlovid on the Horizon
The days of getting COVID treatments like Paxlovid for free are coming to an end, my friends. Brace yourselves! These medications will soon enter the private market, so get ready to reach for your wallets. According to a report from the Associated Press, a five-day course of Paxlovid, the Pfizer-made wonder drug, will cost you a whopping $1,390.
But fear not, dear reader! Merck, known for its COVID treatment Lagevrio, has said it won’t leave you penniless. Merck plans to offer the treatment for free to patients who couldn’t afford it otherwise. How generous! However, don’t get too comfortable, because nothing in life is truly free. Once the federal government’s stash of previously purchased meds runs out, those of you with private insurance may find a sneaky little co-pay charge waiting for you at the pharmacy counter. They always find a way to getcha!
Okay, breathe. It’s not all doom and gloom. There’s still hope for those without medical insurance or relying on Medicaid and Medicare. You won’t have to empty your pockets to get these treatments until 2024. And as for Paxlovid, Pfizer is offering co-pay assistance through 2028. See, the big pharma companies do have a heart… or at least a clever marketing strategy.
Now, let’s not forget about our brave veterans, members of the armed forces, and the Indian Health Service. They will still have access to government stockpiles of Paxlovid, ensuring that they too can bounce back from the clutches of COVID.
But wait, there’s more! The federal government will keep one million treatment courses in its stockpile. Perhaps they’re preparing for a COVID-themed party? Just kidding, they’re making sure that we’re covered in case of any future emergencies. Thanks, Uncle Sam!
- A Fresh Look at Eye Strain: Tips to Give Your Peepers a Break
- TikTok’s Autism Advice Tread With Caution, Not Confidence
- FDA Issues Warning on Dangers of Probiotic Products for Preemie Babies
Last but not least, Pfizer wants to assure us that they’re committed to a smooth commercial transition. How thoughtful! They’re working closely with the U.S. government and healthcare superheroes to ensure that all eligible patients have access to this important medicine. So, they’re not all bad guys after all.
Medical suppliers, rejoice! You can finally place your orders for these treatments starting this week. It’s like Christmas morning for you, except instead of toys, you’ll be receiving life-saving medications. Just try not to get too caught up in the excitement, okay?
Oh, and let’s not forget that the U.S. Food and Drug Administration gave full approval to Paxlovid earlier this year. Applause! This fabulous drug is designed for adults with COVID who face a high risk of hospitalization or death. Think older adults or those with chronic conditions like obesity, diabetes, or asthma. It’s a game-changer, folks!
So, let’s brace ourselves for this new era where COVID meds come with price tags. It’s not the most cheerful news, but at least we’re still able to access these treatments. Let’s be grateful for that. Stay safe, stay healthy, and keep fighting the good fight!
Source: Associated Press
